SALT LAKE CITY — Rozerem (ramelteon), a melatonin agonist, was found both safe and effective in a laboratory model of transient insomnia. More »

SALT LAKE CITY — Rozerem (ramelteon), a melatonin agonist, was found both safe and effective in a laboratory model of transient insomnia. More »

A 60-year-old woman complains that she has had "no energy" for the past 6 months. She wants to know how she can get a better night's sleep and inquires about new insomnia medications she has seen advertised on television. More »

CMEducator: Insomnia and Its Risks: Causes, Consequences and Treatment - application for credit only; article not available online More »

Psychiatric Reporter: Insomnia and Its Risks: Causes, Consequences and Treatment More »

Patients who use or abuse alcohol and other substance are at high risk for insomnia and present unique challenges for treating this debilitating disease. The three avenues of treatment--behavioral, OTC medications and prescription medications--are reviewed and future trends are outlined. More »

espite the fact that about 30% of our life is spent sleeping and decades of research have been spent on sleep, we still do not know its real function. What we do know is lack of sleep can have serious implications, such as increased risk of depressive disorders, impaired breathing and heart disease. On the other hand, nighttime sleep disturbance is usually followed by excessive daytime sleepiness that is associated with delayed problems like memory deficits and impaired social and occupational... More »